Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 07, 2020
Inceptua and Portola have entered into an agreement whereby Inceptua will become Portola’s exclusive distribution partner for Ondexxya® in selected countries.
read more
CoreRx and Aimmune Therapeutics announced their expansion of Myerlake-3.
read more
Alcami Corporation announced the retirement of Patrick Walsh and the subsequent appointment of Bill Humphries as the next CEO, effective June 5th, 2023. With this appointment, Humphries will also join the company's Board of Directors.
read more
Wednesday, September 19, 2012
Vince & Associates Clinical Research announced it has been awarded a contract with the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to carry out clinical pharmacology studies to determine the pharmacokinetics and...
read more
AMRI has signed a definitive agreement to acquire all outstanding shares of Prime European Therapeuticals S.p.A., also known as "Euticals", in a transaction valued at approximately $358 million (EUR 315 million), consisting of shares of AMRI common ...
read more
Quintiles has announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and analytical expertise to help enhance the efficiency ...
read more
Avista Healthcare Partners and Damier Group have signed a definitive agreement to acquire sanotact Group GmbH, an established and innovative German vitamins, minerals, and supplements ("VMS") platform.
read more
Wednesday, January 11, 2017
SGS has announced the forthcoming availability of a new strain of influenza virus for use as a challenge agent in clinical trials. The synthetic virus may be used to test the efficacy of both novel influenza drugs and vaccines in healthy volunteers.
read more
Tuesday, February 26, 2013
Althea Technologies, Inc., a leading provider of biopharmaceutical development and manufacturing services, and Profectus BioSciences Inc, a technology based vaccine company, today announced the signing of a manufacturing supply agreement for plasmid ...
read more
Recipharm and Sanofi announced they have signed an agreement to transfer the Holmes Chapel site from Sanofi to Recipharm.
read more
Tuesday, January 22, 2019
PCI announced further investment in its infrastructure for packaging of controlled substances.
read more
Harbour BioMed has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167.
read more
Thursday, January 14, 2021
Mogrify and the MRC Laboratory of Molecular Biology (LMB) have announced an exploratory research collaboration.
read more
Wednesday, January 28, 2015
Recipharm, the leading contract development and manufacturing organisation (CDMO), is pleased to announce its readiness for serialisation and the successful completion of a complex serialisation project for China on behalf of one of its customers. A ...
read more
Teknova has completed the process of FDA notification for its Active Viral Transport Medium (ATM).
read more